Literature DB >> 19019927

Ophthalmological abnormalities in children with congenital disorders of glycosylation type I.

E Morava1, H N Wosik, J Sykut-Cegielska, M Adamowicz, M Guillard, R A Wevers, D J Lefeber, J R M Cruysberg.   

Abstract

BACKGROUND: Children with congenital disorders of glycosylation (CDG) type Ia frequently present with ocular involvement and visual loss. Little is known, however, about the occurrence of ophthalmological abnormalities in other subtypes of CDG syndrome.
METHODS: We evaluated 45 children sequentially diagnosed with CDG type I for the presence of ocular abnormalities at the time of the diagnosis and during follow-up. We compared the various ophthalmic findings in the different CDG subgroups.
RESULTS: Of the 45 patients, 22 had CDG type Ia, nine had CDG type Ic and 14 had a so-far undiagnosed biochemical background (CDG type Ix). We found ocular anomalies in 28 of the 45 children. Three had unique findings, including congenital cataract, retinal coloboma and glaucoma. A few CDG type Ia patients showed a sequential occurrence of symptoms, including retinitis pigmentosa or cataract.
CONCLUSIONS: Ophthalmic findings are frequent in CDG syndrome involving both the anterior and posterior segment of the eye. The disorder might lead to abnormal development of the lens or the retina, cause diminished vision, alter ocular motility and intraocular pressure. We suggest routine screening and follow-up for ophthalmological anomalies in all children diagnosed with CDG syndrome to provide early treatment and adequate counselling.

Entities:  

Mesh:

Year:  2008        PMID: 19019927     DOI: 10.1136/bjo.2008.145359

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  21 in total

1.  Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.

Authors:  Dorothy A Thompson; Ruth J Lyons; Isabelle Russell-Eggitt; Alki Liasis; Herbert Jägle; Stephanie Grünewald
Journal:  J Inherit Metab Dis       Date:  2013-02-22       Impact factor: 4.982

2.  A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism.

Authors:  Eva Morava; Ron A Wevers; Vincent Cantagrel; Lies H Hoefsloot; Lihadh Al-Gazali; Jeroen Schoots; Arno van Rooij; Karin Huijben; Connie M A van Ravenswaaij-Arts; Marjolein C J Jongmans; Jolanta Sykut-Cegielska; Georg F Hoffmann; Peter Bluemel; Maciej Adamowicz; Jeroen van Reeuwijk; Bobby G Ng; Jorieke E H Bergman; Hans van Bokhoven; Christian Körner; Dusica Babovic-Vuksanovic; Michel A Willemsen; Joseph G Gleeson; Ludwig Lehle; Arjan P M de Brouwer; Dirk J Lefeber
Journal:  Brain       Date:  2010-09-17       Impact factor: 13.501

3.  SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder.

Authors:  Vincent Cantagrel; Dirk J Lefeber; Bobby G Ng; Ziqiang Guan; Jennifer L Silhavy; Stephanie L Bielas; Ludwig Lehle; Hans Hombauer; Maciej Adamowicz; Ewa Swiezewska; Arjan P De Brouwer; Peter Blümel; Jolanta Sykut-Cegielska; Scott Houliston; Dominika Swistun; Bassam R Ali; William B Dobyns; Dusica Babovic-Vuksanovic; Hans van Bokhoven; Ron A Wevers; Christian R H Raetz; Hudson H Freeze; Eva Morava; Lihadh Al-Gazali; Joseph G Gleeson
Journal:  Cell       Date:  2010-07-15       Impact factor: 41.582

4.  Phenotypic Expansion of Congenital Disorder of Glycosylation Due to SRD5A3 Null Mutation.

Authors:  Beyhan Tuysuz; Davut Pehlivan; Ahmet Özkök; Shalini Jhangiani; Cengiz Yalcinkaya; Çiğdem Aktuğlu Zeybek; Donna Marie Muzny; James R Lupski; Richard Gibbs; Jaak Jaeken
Journal:  JIMD Rep       Date:  2015-07-29

5.  NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy.

Authors:  Ahmet Okay Caglayan; Sinan Comu; Jacob F Baranoski; Yesim Parman; Hande Kaymakçalan; Gozde Tugce Akgumus; Caner Caglar; Duygu Dolen; Emine Zeynep Erson-Omay; Akdes Serin Harmanci; Ketu Mishra-Gorur; Hudson H Freeze; Katsuhito Yasuno; Kaya Bilguvar; Murat Gunel
Journal:  Eur J Med Genet       Date:  2014-09-09       Impact factor: 2.708

6.  From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG).

Authors:  Livia Kapusta; Nili Zucker; George Frenckel; Benjamin Medalion; Tuvia Ben Gal; Einat Birk; Hanna Mandel; Nadim Nasser; Sarah Morgenstern; Andreas Zuckermann; Dirk J Lefeber; Arjen de Brouwer; Ron A Wevers; Avraham Lorber; Eva Morava
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

7.  Nijmegen paediatric CDG rating scale: a novel tool to assess disease progression.

Authors:  Samira Achouitar; Miski Mohamed; Thatjana Gardeitchik; Saskia B Wortmann; Jolanta Sykut-Cegielska; Regina Ensenauer; Hélène Ogier de Baulny; Katrin Õunap; Diego Martinelli; Maaike de Vries; Robert McFarland; Dorus Kouwenberg; Miranda Theodore; Frits Wijburg; Stephanie Grünewald; Jaak Jaeken; Ron A Wevers; Leo Nijtmans; Joanna Elson; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2011-05-04       Impact factor: 4.982

8.  Macular hypoplasia in congenital disorder of glycosylation type ia.

Authors:  Bob Z Wang; Pradeep Siriwardana; Deepa Taranath
Journal:  Case Rep Ophthalmol       Date:  2012-04-30

Review 9.  ALG8-CDG: novel patients and review of the literature.

Authors:  Michaela Höck; Karina Wegleiter; Elisabeth Ralser; Ursula Kiechl-Kohlendorfer; Sabine Scholl-Bürgi; Christine Fauth; Elisabeth Steichen; Karin Pichler; Dirk J Lefeber; Gert Matthjis; Liesbeth Keldermans; Kathrin Maurer; Johannes Zschocke; Daniela Karall
Journal:  Orphanet J Rare Dis       Date:  2015-06-12       Impact factor: 4.123

10.  The peroxisomal disorder spectrum and Heimler syndrome: Deep phenotyping and review of the literature.

Authors:  Malena Daich Varela; Priyam Jani; Wadih M Zein; Precilla D'Souza; Lynne Wolfe; Jennifer Chisholm; Christopher Zalewski; David Adams; Blake M Warner; Laryssa A Huryn; Robert B Hufnagel
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-08-31       Impact factor: 3.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.